GL CHEMTEC Partners with Edgewater Capital to Accelerate Growth

Investment in Response to Increased Demand for North American-Based Chemistry Services OAKVILLE, Ontario–(BUSINESS WIRE)–GL CHEMTEC (“GLC”), a specialist in advanced chemistry R&D and scale-up services to support Active Pharmaceutical Ingredient (“API”) development, and the development of advanced materials for drug delivery, medical devices, and other life science applications, today announced it is partnering with Edgewater … [Read more…]

Global Ophthalmic Viscoelastic Devices Market Report 2022-2030 Featuring Carl Zeiss Stiftung, Bausch Health Companies, Johnson & Johnson, Alcon, Rayner Intraocular Lenses, & Aurolab – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. Ophthalmic Viscoelastic Devices Market Report is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area. The model discusses in detail the … [Read more…]

Levita Magnetics Secures $26M to Advance Disruptive Surgical Robotic System

Series C financing to support regulatory process and initial market entry of the Levita® MARS™ platform designed to make robotic surgery accessible for all MENLO PARK, Calif.–(BUSINESS WIRE)–Levita Magnetics, on a mission to provide patients with more access to better surgery, today announced the closing of its $26 million Series C financing, which will be … [Read more…]

Privately Held Alvogen Announces Favorable Ruling on Patents Related to the Company’s Proposed Generic to Xifaxan® for IBS-D

MORRISTOWN, N.J.–(BUSINESS WIRE)–Alvogen, a privately held pharmaceutical company focused on developing, manufacturing and selling generic and branded products, announced today a favorable district court ruling on multiple patents related to the company’s proposed generic to Xifaxan®, a treatment for irritable bowel syndrome with diarrhea (IBS-D) in adults. “We are extremely pleased with the district court’s … [Read more…]

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

MALVERN, Pa. & BRISBANE, Australia–(BUSINESS WIRE)–Alliance Pharma (Alliance), a global leader in bioanalytical and CMC testing services in the pharmaceutical and biopharmaceutical industry, today announced they will be opening a bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia. The 20,000-square-foot purpose-built facility supporting preclinical and clinical testing will be fully operational in November 2022. … [Read more…]

PsiOxus Therapeutics Appoints Howard Davis, Ph.D. as Chief Executive Officer

Dr. Davis brings more than 20 years of industry experience to lead the advancement of the company’s clinical stage pipeline of T-SIGn® immuno-oncology therapeutics for the treatment of solid tumors New CEO will establish U.S. operations in the Boston area to accelerate the company’s mission to positively impact the lives of people living with cancer … [Read more…]

UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

Reported Jelmyto® net product revenue of $16.6 million, a 22% increase from the first quarter of 2022, and 28% increase YoY; reaffirmed 2022 full-year revenue guidance of $70-$80 million Enrollment of UGN-102 Phase 3 single-arm, ENVISION pivotal trial in subjects with low-grade intermediate risk non-muscle invasive bladder cancer (LG-IR-NBIMC) is ongoing and on track; enrollment … [Read more…]

CareDx and MOTTEP Co-Host Health Equity Summit

Panelists Offer Different Perspectives to Address Health Disparities in Organ Transplantation BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will co-host, along with MOTTEP (Minority Organ Tissue Transplantation Education Program), … [Read more…]

Global Cardiovascular Imaging Equipment Pipeline Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information about the Cardiovascular Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about … [Read more…]

Avivagen Announces Receipt of Repeat Order from Asian Customer

OTTAWA, Ontario–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce that one of its most important customers in Asia has placed a … [Read more…]